新型压电肿瘤标志物微阵列免疫传感器的研究

采用螺旋固定夹具构建一种新型插拔式压电石英晶体传感器,巯基化自组装技术固定抗人甲胎蛋白(AFP)、癌胚抗原(CEA)和前列腺特异抗原(PSA)的单克隆抗体,并组装成2×5型压电肿瘤标志物微阵列免疫传感器.研究了压电肿瘤标志物微阵列免疫传感器的响应特性及其影响因素.该微阵列传感器在AFP、CEA和PSA浓度分别为20～640 μg/L、1.56～50 μg/L和1.25～50 μg/L,压电石英晶体振荡频率偏移值对肿瘤标志物浓度呈现良好的响应特性.微阵列传感器用于68例临床血清标本的测定,结果与免疫化学发光法一致;相关系数分别为0.92、0.90和0.91.     

插拔式压电肿瘤标志物微阵列免疫传感器的研制

以AT切型、基频10 MHz的金膜石英晶体作为换能器,通过螺旋检测池固定夹具构建一种新型插拔式压电石英晶体传感器,并组装成2×5型压电肿瘤标志物微阵列免疫传感器。研究了传感器的响应特性及参数。该微阵列传感器在甲胎蛋白(AFP)、癌胚抗原(CEA)、前列腺特异性抗原(PSA)和人绒毛膜促性腺激素(hCG)质量浓度分别为20~640μg/L、1.56~50μg/L、1.25~50μg/L、2.5~250 mIU/mL的范围内,压电石英晶体振荡频率偏移值对肿瘤标志物浓度均呈现良好的响应特性。应用微阵列传感器测定68例临床血清标本,结果与化学发光免疫分析法符合(相关系数分别为0.92、0.90、0.91、0.94)。该压电肿瘤标志物传感器微阵列具有结构简单、操作方便、稳定性好、灵敏度和特异性高,不需标记,能实时检测和重复使用等优点,可用于临床实验诊断,具有临床推广应用价值。     

蛋白A定向固定抗体的纤维蛋白压电免疫传感器的研究

将9MHz双面镀金石英晶体浸入蛋白A溶液中,在晶体电极表面形成一层均匀的蛋白A薄层,用于定向固定人体纤维蛋白抗体.在蛋白A层上形成一层有序致密的自组装抗体分子膜,研制成一种新型的用于人体纤维蛋白检测的压电免疫传感器.比较了3种固定抗体方法的效果,从传感器的灵敏度、稳定性、重现性等考虑,蛋白A吸附法优于聚乙烯亚胺及牛血清白蛋白固定抗体的方法.研究了蛋白A浓度、抗体效价以及抗原抗体反应时间等对传感器灵敏度的影响,考察了电极的选择性和再生能力.纤维蛋白在1×10^-4～1×10^-2g/L浓度范围内有良好响应.     

基于酶催化银沉积质量放大的血吸虫压电免疫传感器的研究

发展了一种基于酶催化金属银沉积信号放大的新型高灵敏气相压电免疫传感检测技术.先将血吸虫抗原(SjAg)共价固定在石英晶体表面,制备得到血吸虫压电免疫传感器.检测时,在晶振上滴加不同浓度的待测血吸虫抗体,再将碱性磷酸酶标记的二抗通过夹心方式结合到传感器表面.然后利用碱性磷酸酶催化磷酸化的抗坏血酸酯水解从而还原硝酸银,使金属银沉积在晶振表面上,放大传感器的质量响应信号.实验结果表明该传感检测方法可显著提高气相压电免疫传感器的检测灵敏度,传感器对血吸虫抗体的响应线性范围在1～225 ng/mL,检测下限为1 ng/mL.     

甲胎蛋白压电免疫传感器的研究

以合成的甲基丙烯酸甲酯和甲基丙烯酸羟乙酯共聚作载体，在压电石英晶体表面涂覆共聚物涂层，经ＣＮＢｒ活化后固定ＡＦＰ抗体，研制成ＡＦＰ压电晶体免疫传感器，研究了固定化方法，载体量，抗原抗体结合时间，重现性选择性等实验条件和参数的影响，压电晶体的频移值与ＡＦＰ浓度在１００ｎｇ／ｍＬ～８００ｎｇ／ｍＬ的范围内有良好的线性关系，将此传感器初步用于人体血清样品的测定，并与放射免疫法对照，结果令人满意。     

丙肝压电免疫传感器的研制

研制了一种用于丙肝抗原检测的新型传感器——压电免疫传感器。采用AT切型、基频为10MHz伍英晶体作为换能器,先在晶体表面崮定巯基丙酸（MPA）,经过EDC和NHS活化后固定丙肝抗原（HCVAg）、最后检测不吲浓度的标准抗体溶液？分别研究了它的重复性和灵敏度,并通过临床验证了它的准确性此传感器其有灵敏度高、特异性好、不需标记、操作简单、能实时在线检测和重复使用等优点,能用于临床实验诊断、具有临床推广应用价值。     

基于金属离子螯合的压电免疫传感器新型固定化方法

提出了一种基于金属离子螯合作用的压电免疫传感器新型固定化方法. 先在压电石英晶振表面沉积正丁胺等离子体聚合膜(BA-PPF), 再在BA-PPF表面修饰可与金属离子螯合的氨三乙酸基团, 用金属铜离子活化后, 修饰了二乙三胺五乙酸基团的IgG抗体蛋白质分子即可螯合固定于BA-PPF上. 将固定了抗体的压电石英传感器用于正常人免疫球蛋白IgG (NHIgG)的测定, 其频率响应与NHIgG浓度在0.36～63.8 μg/mL范围内存在良好的线性关系. 这种新型压电免疫传感器固定化方法简单快速, 具有良好的通用性.     

基于Nafion膜修饰的血吸虫抗体压电免疫传感器研究

将Nafion膜包埋血吸虫抗原固定在石英晶体微天平表面上,构制了用于测定血清中血吸虫抗体的压电免疫传感器.这种生物敏感膜由涂敷在石英晶片表面上的一滴Nafion+血吸虫抗原磷酸盐缓冲液干燥而成,它的构制和再生过程具有良好的重现性.用扫描电镜观察了这种生物敏感膜的形貌,并对传感器的构制参数、测量条件进行了优化,优化的传感器对血吸虫抗体的检测范围为0.2～6.0 mg/L.本传感器具有仪器简单、操作方便、灵敏度高、重现性好等优点,可判断血吸虫感染情况.     

基于网状混合自组装膜的压电免疫传感器及其应用

结合纳米金及混合自组装技术, 制备了一种新型网状混合膜, 提出了一种新的生物分子固定化方法, 研制了一种用于检测人血清抗精子抗体的压电免疫传感器. 首先, 将纳米金溶胶、巯基丙酸和1,6-二巯基己烷按一定的比例混合制得网状混合自组装膜, 然后将此膜组装到压电石英晶振的金电极表面, 经EDC/NHS活化后, 再将抗原固定到电极上, 实现对抗精子抗体的检测. 结果表明, 该方法能明显提高抗体抗原结合效率, 从而提高传感器的灵敏度, 并降低传感界面的非特异性吸附. 将此传感器应用于人血清抗精子抗体的检测, 线性范围为10~800 mU/mL, 检出限为7 mU/mL. 此传感器为抗精子抗体的临床检测提供了新平台.     

纳米金-蛋白A介导抗体定向固定的压电传感及电化学特性研究

以纳米金为载体标记蛋白A(PA),用于介导抗体在压电石英晶体金电极表面的定向固定化.以补体C_1q抗体为模型,采用压电传感技术实时监察了此敏感界面的免疫反应过程,并考察了与补体C_1q免疫反应的压电响应性能.金标PA固定抗体的方法与传统的直接PA固定化方法相比较,具有传感界面无需活化,固定抗体的免疫活性高等优点,可对相应抗原进行高灵敏的压电免疫检测.分别利用循环伏安和电化学交流阻抗技术对金标PA固定抗体及其免疫反应的动力学过程进行了表征.     

用于液相中检测的压电免疫传感器研究

利用聚乙烯亚胺法,将Ｃ２型葡萄菌肠毒素（ＳＥ）抗体固化在未抛光的压电晶体的金电极上,利用双调式振荡电路制作的振荡器,构建压电免疫传感器,其稳定性,特异性都较好。     

补体C1q压电免疫传感器的研究

研制了一种可重复使用的压电免疫传感器用于检测补体C1q.比较了聚乙烯亚胺粘附、戊二醛交联法,物理吸附法以及蛋白A法三种固定化抗体蛋白的方法.使用蛋白A法,补体C1q在所测浓度范围内有良好的线性关系.使用过的晶片用0.1 mol/L柠檬酸盐缓冲溶液(pH 3.0)解吸,可重复使用4次.     

压电免疫传感器用于B因子的测定

B因子是一种不耐热的球蛋白,它参与机体的防御,在炎症过程、细胞和组织损伤中均起重要作用.B因子的检测方法常用的有单扩散法、火箭电泳法和溶血法,前者灵敏度不高,重复性差;后两者操作较复杂^[1,2].     

Detection of complement C1-inhibitor with a piezoelectric immunosensor

A novel piezoelectric immunosensor has been developed for the detection of human complement C1-inhibitor. Anti-C1-inhibitor antibody was immobilized onto the gold electrodes of a 9 MHz AT-cut piezoelectric crystal. Coating the crystal with polyethyleneimine adhesion, followed by a glutaraldehyde cross-linking method to immobilize antibody showed better results than the physical adsorption method with respect to sensitivity and reproducibility. Under the optimized experimental conditions, the sensor showed good response to the C1-inhibitor in the range from 2.0 × 10^–8 to 1.2 × 10^–6 g. Other proteins in human serum did not remarkably interfere with the detection. The crystals could be regenerated 5 times, when bound materials on the crystal surface were eluted by strong acid and strong alkali solution and subsequently cleaned in an ultrasonic cleaner.     

A novel piezoelectric immunosensor for detection of carcinoembryonic antigen

A simple, rapid, and highly sensitive immunosensor for the direct determination of carcinoembryonic antigen (CEA) in human serum using a piezoelectric crystal has been developed and optimized. In order to improve sensitivity of the immunosensor, a protein A-based orientation-controlled immobilization method for antibodies was adopted together with an immunoreactive accelerant of polyethyleneglycol (PEG) used to amplify the signal response of frequency. Human normal serum was utilized as a reference background. The linear range for CEA concentration obtained by the end-point method was 66.7-466.7 ng/mL. Clinical samples from cancer patients were analyzed by the proposed piezoelectric immunoassay, and the analytical results were reasonably comparable with those obtained by the chemiluminescence immunoassay (CLIA). The proposed immunosensor provides a new promising method for the highly sensitive immunoassay of CEA in clinical laboratory.     

A piezoelectric immunoassay based on self-assembled monolayers of cystamine and polystyrene sulfonate for determination of Schistosoma japonicum antibodies

A piezoelectric immunosensor based on an improved immobilization strategy combining self-assembled monolayers (SAM) of cystamine (Cys) and polystyrene sulfonate (PSS) has been developed for the determination of Schistosoma japonicum antibodies (SjAb) in rabbit serum. Cys SAM were first applied to the gold electrode surface of the crystal, serving as a positively-charged base. Schistosoma japonicum antigen (SjAg) was then electrostatically immobilized on the crystal by means of a negatively-charged PSS layer. When sealed by use of an appropriately selected blocking reagent for BSA and normal rabbit serum (NRS), non-specific adsorption could be substantially reduced.The immunosensor was used to determine SjAb in optimized buffer medium with addition of poly(ethylene glycol) (PEG), which served as an immunoreaction enhancer. It was shown experimentally that SjAg immobilized by the Cys-PSS adsorption procedure had higher immunological activity or binding efficiency than those immobilized by the glutaraldehyde (GLU) binding or direct attachment procedures. The immunosensor developed had satisfactory sensitivity and detection limit, and regeneration of the piezoelectric quartz-crystal was easy. Analytical results obtained with infected rabbit serum samples indicated that the proposed immunosensor is a promising alternative for qualitative and quantitative determination of SjAb in clinical diagnosis of infection with Schistosoma japonicum.     

Detection of complement C1-inhibitor with a piezoelectric immunosensor

A novel piezoelectric immunosensor has been developed for the detection of human complement C1-inhibitor. Anti-C1-inhibitor antibody was immobilized onto the gold electrodes of a 9 MHz AT-cut piezoelectric crystal. Coating the crystal with polyethyleneimine adhesion, followed by a glutaraldehyde cross-linking method to immobilize antibody showed better results than the physical adsorption method with respect to sensitivity and reproducibility. Under the optimized experimental conditions, the sensor showed good response to the C1-inhibitor in the range from 2.0 x 10(-8) to 1.2 x 10(-6) g. Other proteins in human serum did not remarkably interfere with the detection. The crystals could be regenerated 5 times, when bound materials on the crystal surface were eluted by strong acid and strong alkali solution and subsequently cleaned in an ultrasonic cleaner.     

Using a piezoelectric flow immunosensor for determining sulfamethoxazole in environmental samples

A mass-sensitive piezoelectric flow immunosensor for determining sulfo preparations in liquid media was proposed. This sensor included a piezoelectric quartz resonator with silver electrodes on the silanized surface of which sulfamethoxazole-protein conjugates were immobilized. The binding constants of antibodies with the conjugate sulfamethoxazole were determined, and the most active complementary pairs were chosen. The selectivity of determining sulfamethoxazole in the presence of its structural analogues was evaluated based on the cross reaction percentages. A procedure for the flow-injection determination of sulfamethoxazole was developed using the piezoelectric immunosensor as a detector; the detection limit of sulfamethoxazole was 0.15 ng/mL. The procedure was tested in determining sulfamethoxazole in soil and natural water.     

A novel antibody–antigen based impedimetric immunosensor for low level detection of HER2 in serum samples of breast cancer patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-ionic liquid electrode

A highly sensitive impedimetric immunosensor based on a gold nanoparticles/multiwall carbon nanotube-ionic liquid electrode (AuNPs/MW-CILE) was developed for the determination of human epidermal growth factor receptor 2 (HER2). Gold nanoparticles were used to enhance the extent of immobilization and to retain the immunoactivity of the antibody Herceptin on the electrode. Cyclic voltammetry and electrochemical impedance spectroscopy were employed for characterization of various layers coated onto the AuNPs/MW-CILE. The impedance measurements at different steps were based on the charge transfer kinetics of the [Fe(CN)₆]^3−/4− redox pair. The immobilization of antibody and the corresponding antigen–antibody interaction at the electrode surface altered the interfacial electron transfer. The interactions of antibody with various concentrations of antigen were also monitored via the change of impedance response. The results showed that the charge transfer resistance increases linearly with increasing concentrations of HER2 antigen. The linear range and limit of detection were found as 10–110 ng mL⁻¹ and 7.4 ng mL⁻¹, respectively. The sensitivity and specificity of the immunosensor were validated. The results showed that the prepared immunosensor is a useful tool for screening of trace amounts of HER2 in serum samples of breast cancer patients.